Top compounds associated with response to VGLL3


Feature Type Standardized
Nominal ANOVA
mRNA GSK2126458 GDSC1000 pan-cancer AAC -0.058 0.08
mRNA RG-108 CTRPv2 pan-cancer AAC 0.064 0.08
mRNA CUDC-101 GDSC1000 pan-cancer AAC -0.056 0.08
mRNA JW-7-24-1 GDSC1000 pan-cancer AAC -0.054 0.08
mRNA SNX-2112 GDSC1000 pan-cancer AAC -0.054 0.08
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.061 0.08
mRNA SN-38 CTRPv2 pan-cancer AAC -0.064 0.08
mRNA Cytarabine GDSC1000 pan-cancer AAC 0.064 0.08
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.062 0.08
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.061 0.09
Download CSV